DBIA
CVS icon

Dumont & Blake Investment Advisors’s CVS Health CVS Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Buy
14,798
+8,854
+149% +$682K 0.27% 97
2025
Q4 		$472K Buy
5,944
+20
+0.3% +$1.58K 0.11% 141
2025
Q3 		$447K Sell
5,924
-314
-5% -$21.5K 0.11% 145
2025
Q2 		$430K Sell
6,238
-125
-2% -$8.2K 0.11% 142
2025
Q1 		$431K Sell
6,363
-25
-0.4% -$1.5K 0.12% 145
2024
Q4 		$287K Sell
6,388
-137
-2% -$7.69K 0.08% 169
2024
Q3 		$410K Sell
6,525
-6,783
-51% -$396K 0.11% 150
2024
Q2 		$786K Buy
13,308
+964
+8% +$60.3K 0.11% 150
2024
Q1 		$985K Buy
12,344
+69
+0.6% +$5.27K 0.28% 91
2023
Q4 		$969K Sell
12,275
-1,386
-10% -$98.6K 0.3% 89
2023
Q3 		$954K Buy
13,661
+38
+0.3% +$2.69K 0.32% 82
2023
Q2 		$942K Sell
13,623
-561
-4% -$39.9K 0.31% 84
2023
Q1 		$1.05M Buy
14,184
+60
+0.4% +$5.03K 0.36% 78
2022
Q4 		$1.32M Sell
14,124
-160
-1% -$15.4K 0.47% 65
2022
Q3 		$1.36M Sell
14,284
-1,687
-11% -$167K 0.51% 54
2022
Q2 		$1.48M Buy
15,971
+13
+0.1% +$1.27K 0.48% 58
2022
Q1 		$1.61M Sell
15,958
-120
-0.7% -$12.6K 0.44% 61
2021
Q4 		$1.66M Sell
16,078
-203
-1% -$18.8K 0.43% 62
2021
Q3 		$1.38M Sell
16,281
-88
-0.5% -$7.37K 0.4% 72
2021
Q2 		$1.37M Buy
16,369
+73
+0.4% +$5.98K 0.39% 76
2021
Q1 		$1.23M Buy
16,296
+90
+0.6% +$6.56K 0.38% 80
2020
Q4 		$1.11M Sell
16,206
-323
-2% -$21K 0.38% 82
2020
Q3 		$965K Buy
16,529
+287
+2% +$17.9K 0.37% 79
2020
Q2 		$1.05M Buy
16,242
+35
+0.2% +$2.2K 0.44% 67
2020
Q1 		$962K Sell
16,207
-113
-0.7% -$7.54K 0.49% 59
2019
Q4 		$1.21M Buy
16,320
+50
+0.3% +$3.51K 0.48% 61
2019
Q3 		$1.03M Sell
16,270
-407
-2% -$24.1K 0.43% 71
2019
Q2 		$909K Buy
16,677
+50
+0.3% +$2.69K 0.38% 82
2019
Q1 		$897K Buy
16,627
+90
+0.5% +$5.55K 0.38% 87
2018
Q4 		$1.08M Buy
16,537
+199
+1% +$14.9K 0.51% 62
2018
Q3 		$1.29M Buy
16,338
+350
+2% +$25K 0.5% 60
2018
Q2 		$1.03M Buy
15,988
+557
+4% +$36.7K 0.43% 79
2018
Q1 		$960K Buy
15,431
+270
+2% +$19.4K 0.41% 85
2017
Q4 		$1.1M Sell
15,161
-420
-3% -$30.5K 0.45% 79
2017
Q3 		$1.27M Sell
15,581
-391
-2% -$30.9K 0.54% 62
2017
Q2 		$1.28M Sell
15,972
-150
-0.9% -$11.8K 0.57% 53
2017
Q1 		$1.27M Buy
16,122
+290
+2% +$23.2K 0.57% 56
2016
Q4 		$1.25M Sell
15,832
-175
-1% -$14.2K 0.59% 52
2016
Q3 		$1.42M Buy
16,007
+250
+2% +$23.6K 0.7% 43
2016
Q2 		$1.51M Sell
15,757
-365
-2% -$36.4K 0.76% 40
2016
Q1 		$1.67M Sell
16,122
-228
-1% -$22.2K 0.86% 33
2015
Q4 		$1.6M Hold
16,350
– – 0.82% 37
2015
Q3 		$1.58M Sell
16,350
-2,012
-11% -$212K 0.85% 37
2015
Q2 		$1.93M Sell
18,362
-5,900
-24% -$603K 0.94% 29
2015
Q1 		$2.5M Sell
24,262
-185
-0.8% -$18.7K 1.22% 16
2014
Q4 		$2.35M Sell
24,447
-150
-0.6% -$13.2K 1.16% 18
2014
Q3 		$1.96M Sell
24,597
-9
-0% -$709 1.01% 29
2014
Q2 		$1.85M Sell
24,606
-330
-1% -$24.9K 0.93% 30
2014
Q1 		$1.87M Sell
24,936
-725
-3% -$51.2K 0.97% 30
2013
Q4 		$1.84M Sell
25,661
-9,029
-26% -$580K 0.95% 32
2013
Q3 		$1.97M Sell
34,690
-40
-0.1% -$2.38K 0.94% 31
2013
Q2 		$1.99M Buy
+34,730
New +$2.01M 1.19% 24

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dumont & Blake Investment Advisors's CVS Position: Q1 2026 in Review

Dumont & Blake Investment Advisors increased its CVS Health (CVS) stake by 149% in Q1 2026, buying an estimated $682K and bringing the position to 14,798 shares worth $1.06M. The position accounts for 0.27% of the portfolio, ranked #97.

Dumont & Blake Investment Advisors first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.5M in Q1 2015. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Dumont & Blake Investment Advisors held 14,798 shares of CVS Health worth $1.06M as of Q1 2026.
  • Dumont & Blake Investment Advisors bought 8,854 CVS Health shares in Q1 2026, an estimated $682K.
  • CVS Health made up 0.27% of Dumont & Blake Investment Advisors's portfolio in Q1 2026, its #97 holding.
  • Dumont & Blake Investment Advisors first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Dumont & Blake Investment Advisors's CVS Health position peaked at $2.5M in Q1 2015.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.